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Background: Studies measuring human growth hormone
(hGH) in blood during exercise have mainly used venous
sampling. The invasive nature of this procedure makes
evaluation of hGH impossible in various exercise environ-
ments.
Objective: To determine whether capillary sampling could
offer an alternative sampling method.
Methods: Capillary and venous blood samples were col-
lected for determination of hGH at the end of each exercise
stage during an incremental exercise test in 16 male club
level competitive cyclists (mean (SD) age 30.8 (8.0) years,
body mass 72.2 (7.1) kg, body fat 12.9 (3.5)%, peak oxygen
consumption 4.18 (0.46) l?min21). Linear regression, from a
plot of venous v capillary blood hGH concentration, showed
a correlation coefficient of r=0.986 (p,0.001). When
geometric means and log transformations were used, a
coefficient of variation of 14.2% was demonstrated between
venous and capillary flow for hGH concentration. The mean
ratio limits of agreement were 0.62 (1.72)—that is, 95% of
the ratios were contained between 0.36 and 1.07, with a
mean of 0.62.
Conclusions: Capillary blood sampling is an acceptable
alternative to venous sampling for determining hGH con-
centration during rest and exercise. Sample sites should not
be used interchangeably: one site should be chosen and its
use standardised.
H
uman growth hormone (hGH) is produced throughout
life, the highest values being measured during puberty.
It is released from the anterior pituitary gland in
response to various stimuli, the most powerful of which are
sleep and exercise. In general, hGH secretion follows a
circadian rhythm and it is secreted in 6–12 discrete pulses per
day, with the largest pulse approximately one hour after the
onset of night-time sleep.
There have been growing numbers of studies examining
the exercise induced hGH response. This response has been
studied during endurance, resistance, and high intensity
exercise.1–3 As well as the more obvious and recognised effects
on growth (for example, on bone, visceral tissue, and
muscle), growth hormone is also believed to affect the way
in which the body uses fat and carbohydrate for energy
during exercise. Specifically, hGH promotes the use of free
fatty acids (FFA) as an energy substrate by inhibiting
glycolysis and by mobilisation of FFA from triacylglycerol
stores.4 5
In general, hGH has been, and continues to be, measured
during exercise in venous outflow, principally from an
antecubital vein. In the exercise sciences there has been
considerable debate over the use of different sampling sites
for measurement of changes in the concentration of analytes
resulting from exercise (particularly blood lactate).6–9 Sample
sites that have previously been used include the antecubital
vein, the anterior ulnar vein, or the femoral vein for venous
blood, the brachial artery or the femoral artery for arterial
sampling, and the fingertip, toe, or earlobe for capillary
sampling.
The invasive nature of venous sampling procedures renders
the evaluation of growth hormone impossible in a variety of
exercise environments. There is little doubt that an easier
method of sample collection—that is, one that is less invasive
and quicker to achieve at each sample point—would be
advantageous and could help the field progress. The use of
the less invasive capillary sampling methodology would
therefore be more acceptable, but there is a dearth of reports
on the use of capillary sampling, let alone its validity. Our
aim in this study was therefore to establish the validity of
measuring hGH concentrations in capillary blood as a more
practical and cost-effective alternative to venous blood
sampling.
METHODS
Following approval by the Harrow ethics committee of the
Northwick Park and St Mark’s Hospital Trust, 16 male club
level competitive cyclists (mean (SD) age 30.8 (8.0) years,
body mass 72.2 (7.1) kg, body fat 12.9 (3.5)%, and peak
oxygen consumption 4.18 (0.46) l?min21) provided written,
informed consent before participating in the study. All
participants were engaged in regular cycle training and
competition and were fit and healthy as determined by
medical history. None of the volunteers had a history of
pituitary, cardiorespiratory, renal, hepatic, or metabolic
disease. Participants were non-smokers and refrained from
exercise for at least 24 hours before each evaluation. Before
testing, subjects had their body composition assessed using
height and body mass (Avery Berkel, Birmingham) and body
fat estimation from the sum of four skinfold sites.10
Testing protocol
Participants completed a continuous incremental cycling test
on an SRM Ergoe cycle ergometer (Schoberer Rad
Messtechnik, Fuchsend, Germany) to volitional exhaustion.
The protocol consisted of six four-minute submaximal efforts
followed by a seventh and final four-minute maximal effort.
During the final effort subjects were instructed to attempt to
cover the greatest distance possible while maintaining a
relatively stable power output.
Throughout the exercise test, expiratory gases (Oxycon
Alpha, Jaeger-Mijnhardt, Groningen, Netherlands) and heart
Abbreviations: FFA, free fatty acids; hGH, human growth hormone;
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rate (Polar Vantage, Polar Electro Oy, Kempele, Finland)
were measured continuously. Capillary (earlobe) blood
lactate concentration was analysed as a single measurement
at the end of each exercise grade using a GM-7 enzymatic
analyser (Analox Instruments, Hammersmith, London, UK).
Blood samples for growth hormone measurement were
collected during the last 45 seconds of each exercise stage
simultaneously from an indwelling cannula inserted into a
forearm vein and from the ear lobe, for capillary determina-
tion. Venous and capillary blood samples for hGH analyses
were collected at –10, 19, 27, 35, 43, 53, 63, and 73 minutes—
that is, two samples (one capillary and one venous) 10
minutes before exercise and after stages 1, 3, 5, and 7 and at
10, 20, and 30 minutes after the cessation of exercise. Saline
was used to flush and so maintain the patency of the cannula
before each venous sample collection.
Capillary samples were collected in 300 ml serum
Microvettes (CB 300 LH, Sarstedt, Nu¨mbrecht, Germany)
placed on ice and spun in a microcentrifuge (Analox,
Hammersmith, London, UK) within 60 minutes.
Supernatant from capillary samples was then transferred to
labelled Eppendorf tubes and frozen at 220 C˚ for subsequent
analysis of hGH concentration. Venous samples were
collected into serum gel vacutainers, placed on ice, and spun
in a refrigerated centrifuge. Supernatant from venous
samples was transferred to labelled Eppendorf tubes and
frozen at 220 C˚ for subsequent analysis.
hGH analysis
Samples were assayed for hGH employing the coated-tube
immunoradiometric assay (IRMA) kit produced by DSL
(DSL-1900 ACTIVE, Diagnostic Systems Laboratories Inc,
Webster, Texas, USA). This can deal with small sample sizes
of 50 ml for analysis of hGH concentrations. In this case hGH
is used as an antigen to produce antibodies in some other
animal species, such as rabbit. These antibodies are then
highly specific to hGH. The antibodies are added to a reaction
vessel containing the serum hGH samples and radiolabel (in
this case 125I). As a result, this type of assay is sometimes
referred to as a ‘‘sandwich assay’’ because the analyte is
sandwiched between solid phase antigen and antibody–
radiolabel complex.
A solid phase support is used for the reaction to take place
on. In this particular assay the solid phase support is provided
by cellulose particles. Cellulose is a stable polymer of glucose
and reactions may take place in aqueous solutions (as in this
case), at a pH of 3–10, and in organic solvents including
dimethylformamide, dimethylsulphide, acetone, and diox-
ane.11
Suspensions of cellulose have the advantage of a large
surface area for immunoreagent or antigen binding.
Efficient mixing during incubation with the analyte allows
rapid and sensitive assays to be carried out. Cellulose
particles are often used in immunoassays where the bound
and free fractions are separated by centrifugation and
washing,12 as in this case.
The DSL assay procedure employs a two site IRMA in
which the analyte to be measured is sandwiched between
two antibodies. The first antibody is immobilised to the inside
walls of the tubes, the second is radiolabelled for detection.
The analyte present in the unknowns, standards, and
controls is bound by both of the antibodies to form a
sandwich complex. Unbound materials are removed by
decanting and washing the tubes. The amount of bound
hGH is directly proportional to the hGH present in the
samples. The radioactivity reflecting the amount of bound
hGH was determined by a 1261 Multigamma on-line counter
(Wallac Oy, Turku, Finland).
Calibration and reliabil ity
A standard calibration curve is produced by using known
growth hormone concentration standards produced by the
supplier of the IRMA kit. These standards undergo the same
process detailed previously and are then run through the
gamma counter.
The theoretical sensitivity, or minimum detection limit,
calculated by the interpolation of the mean + 2SD of 10
replicates of the 0 mg?l21 hGH standards is 0.01 mg?l21. The
intra-assay precision was determined from the mean of 12
replicates with three human serum samples. For 12 replicates
each, sample 1 was 2.91 (0.09) mg?l21 with a coefficient of
variation (CV) of 3.1%, sample 2 was 5.58 (0.22) mg?l21 with
a CV of 3.9%, and sample 3 was 25.84 (1.40) mg?l21 with a CV
of 5.4% (values are mean (SD)).
Statistical analysis
A linear regression plot and correlation coefficient is used to
assess the strength of the relation between hGH concentra-
tion in venous and capillary blood. However, as correlation
does not provide information on the agreement between
the two measures, limits of agreement are used.13 As
Bland and Altman pointed out,13 it is very unlikely that
different methods, or in this case sample sites, will agree
exactly by giving the identical result for all individuals.
The point here is to assess by how much the concentration
of hGH in capillary blood will agree with that in venous
blood. Limits of agreement were felt to be the best method
of distinguishing between two measurements and so this
is the ideal statistical method in this instance, where
determination of the agreement between capillary and
Figure 1 Linear regression plot for venous v capillary blood
determinations of human growth hormone (GH) concentration (94 data
points).
Figure 2 Log-log Bland–Altman plot for agreement between venous
and capillary blood human growth hormone concentration.
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venous samples is required. As the data demonstrate
heteroscedasticity, we used geometric means and standard
deviations calculated using log transformations to determine
the coefficient of variation across three growth hormone
ranges, 0–5, 5–10, and 10–15 mg?l21. Ratio limits of agree-
ment were also calculated.
RESULTS
A significant correlation coefficient (r=0.986, p,0.001) was
observed between venous and capillary samples analysed for
hGH concentration (fig 1). Coefficients of variation of 20.5%
for 0–5 mg?l21, 20.2% for 5–10 mg?l21, and 12.1% for 10–
15 mg?l21 were observed, a coefficient of variation of 14.2%
across the range of hGH measurement. The mean ratio limits
of agreement were 0.62 (1.72)—that is, 95% of the ratios
were contained between 0.36 and 1.07, with a mean of 0.62;
the log-log Bland–Altman plot can be seen in fig 2. Table 1
provides mean (SD) values for venous and capillary hGH
concentrations and for blood lactate at various time points
before and during exercise.
DISCUSSION
Our study is the first to examine the validity of capillary
sampling for determining blood hGH concentration. Our
findings show that there is very good agreement between
capillary and venous blood hGH concentration across a range
of exercise intensities. A correlation coefficient of r=0.986
(p,0.001) was observed between venous and capillary
samples, indicating that in 97% of cases capillary hGH
concentration can predict the concentration in the venous
outflow. A coefficient of variation across the range of
measured hGH values of 14.2% was deemed acceptable.
Hence, both good agreement (as illustrated by mean ratio
limits of agreement of 0.36 to 1.07) and good strength of
relation (as illustrated by an r value of 0.986) were
demonstrated.
The problems of interfering with the movement of limbs
during exercise and the more invasive nature of venous
sampling often restricts the range of situations that will allow
measurement of blood borne analytes. These results are thus
of particular importance when investigating populations
where there are concerns over the use of the more invasive
venous sampling techniques during exercise—for example, in
children, pregnant women, disabled individuals, and elite
athletes. In addition, with capillary sampling reduced ethical
concerns are apparent. Ethical concerns associated with
venous sampling in elite athletes are related to the fact that
there are increased risks of infection and bruising, which
could limit the individual’s ability to earn a living and affect
their quality of life.
Even with such a good correlation and limits of agree-
ment, as with lactate it is best to standardise the sample
site used. Accordingly, if blood is collected from a capillary
site on one occasion, if subsequent comparison is to be
made after a retest, then capillary sampling should again be
used.
The methodological difficulties associated with simulta-
neous collection of an adequate volume of venous and
capillary samples (that is, enough capillary blood for assay
analysis) in 45 seconds highlights the need for repeated
practice. Considerable expertise is required to collect venous
and capillary samples within 45 seconds. We therefore
recommend adequate practice in learning these skills to
guarantee collection of the required volume within 60
seconds, the time after which a return to resting conditions
is believed to begin.14 15 This is important where discontin-
uous exercise protocols are required, for example earlobe
sampling using a treadmill or rowing ergometer. Difficulties
encountered in sample collection include those resulting
from peripheral vasoconstriction, which often accompanies
exercise and affects both capillary and venous sites, coupled
with blood coagulation in the cannulation set despite regular
saline flushing. In addition, excessive squeezing of the
capillary site or vacuum pressure used at the venous site will
increase the risk of lysis of the red blood cells, and this can
interfere with hGH measurement by the assay. Table 1
illustrates the large variation seen in the measurement of
hGH regardless of sample site but this does not detract from
the viability of capillary sampling.
In conclusion, capillary sampling for the determination of
hGH concentration in blood before, during, and after exercise
is an acceptable alternative to venous sampling.
Table 1 Concentrations of human growth hormone and blood lactate
Sample time (min) hGHven (mg?l21) hGHcap (mg?l21) Lactate (mmol?l21)
210 0.56 (0.85) 0.51 (0.69)
19 1.03 (1.33) 1.09 (1.46) 1.31 (0.33)
23 1.51 (0.34)
27 2.21 (1.74) 1.89 (1.45) 1.81 (0.49)
31 2.44 (0.85)
35 5.66 (5.27) 5.03 (5.03) 3.58 (1.53)
39 5.27 (2.53)
43 15.98 (15.05) 12.63 (10.21) 8.45 (2.74)
53 15.98 (15.05) 9.11 (5.23)
63 9.70 (5.48) 6.87 (5.33)
73 6.43 (7.39) 6.52 (7.59)
Values are mean (SD).
hGHcap, growth hormone in capillary blood; hGHven, growth hormone in venous blood.
Take home message
N Much is known on the comparison of blood lactate
collected at different sites, but only one previous study
has measured hGH in capillary blood. No information
on this method or any attempt to validate it has been
published. Therefore, to date, nothing further is known
on the use of capillary hGH measurement in exercise.
N Capillary sampling provides hGH researchers with a
cheaper viable alternative to venous sampling and
therefore increases the range of circumstances, includ-
ing exercise, in which it can be measured. Where
ethical concerns are raised, this enables new popula-
tions to become accessible for research, providing
opportunities for assessing hGH in exercise settings
never before assessed.
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